Erschienen in:
01.07.2024 | RESEARCH LETTER
Novel biomarkers and psoriasis associated cardiovascular risk
verfasst von:
Leopoldo Fernández-Domper, Jose Maria Martin-Hernández, Jose A. Páramo, Leopoldo Fernandez-Alonso, Lucía Martínez-Casimiro, Encarnación Montesinos-Villaescusa, Ángeles Revert-Fernández, Maria Morales-Suarez-Varela
Erschienen in:
Archives of Dermatological Research
|
Ausgabe 5/2024
Einloggen, um Zugang zu erhalten
Excerpt
Despite the established link between psoriasis and cardiovascular risk (CVR), there remains a crucial need for improved risk stratification in these patients [
1‐
3]. Traditional CVR assessment tools, such as the Framingham Risk Score, may underestimate the true risk in individuals with psoriasis due to the unique pathophysiological mechanisms involved. Hence, there is a growing interest in identifying novel biomarkers that can better predict CVR specifically in psoriasis patients [
4,
5]. …